Clinical trial
Pharmacogenetic Study of Pioglitazone and Quetiapine XR Treatment Response in Mood Disorders
NCT01342380 is registered in ClinicalTrials.gov with University Hospitals Cleveland Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Pharmacogenetic Study of Pioglitazone and Quetiapine XR Treatment Response in Mood Disorders
- Lead sponsor
- University Hospitals Cleveland Medical Center
- Phase
- Observational
- Overall status
- Completed
- Start date
- February 28, 2011
- Completion date
- May 31, 2015
- Enrollment
- 42 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.